Technology

AddToAny

Google+ Facebook Twitter Twitter

Sebia enters agreement

The test mitigates the potential interference in visualisation of M-proteins in immunofixation electrophoresis caused by DARZALEX. 

bio

DARZALEX is a human monoclonal antibody targeting CD38 that provides superior clinical benefit to monotherapy in heavily pre-treated multiple myeloma (MM) patients and when combined with standard of care regimens for the treatment of MM. 
sebia.com

Related Articles

Viral suppression helps to prevent AIDS-defining cancers

Early, sustained antiretroviral therapy that results in long-term viral suppression, helps to prevent AIDS-defining cancers and, to a lesser degree, non-AIDS-defining cancers, it is claimed.

New flow cytometer

News flow cytometer

Merck, a leading science and technology company, has now launched its new CellStream flow cytometry system.

Journal-based learning: iStock

April Journal-based learning

Each article’s contents should be read, researched and understood, and you should then come to a decision on each question. The pass mark is 17 out of 20 questions answered correctly. JBL exercises may be completed at any time until the published deadline date. Please select your choice of correct answers and complete the exercises online at: www.ibms.org/cpd/jbl

Primary HPV cervical screening

Following meetings with the British Association for Cytopathology (BAC), Public Health England (PHE) and the IBMS, the following has been agreed.

Top